Cargando…

Biologika gegen schweres instabiles Asthma

Detalles Bibliográficos
Autor principal: Meißner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370781/
https://www.ncbi.nlm.nih.gov/pubmed/34421463
http://dx.doi.org/10.1007/s11298-021-2083-2
_version_ 1783739505849663488
author Meißner, Thomas
author_facet Meißner, Thomas
author_sort Meißner, Thomas
collection PubMed
description
format Online
Article
Text
id pubmed-8370781
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-83707812021-08-18 Biologika gegen schweres instabiles Asthma Meißner, Thomas CME (Berl) Schwerpunkt Springer Medizin 2021-08-24 2021 /pmc/articles/PMC8370781/ /pubmed/34421463 http://dx.doi.org/10.1007/s11298-021-2083-2 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Schwerpunkt
Meißner, Thomas
Biologika gegen schweres instabiles Asthma
title Biologika gegen schweres instabiles Asthma
title_full Biologika gegen schweres instabiles Asthma
title_fullStr Biologika gegen schweres instabiles Asthma
title_full_unstemmed Biologika gegen schweres instabiles Asthma
title_short Biologika gegen schweres instabiles Asthma
title_sort biologika gegen schweres instabiles asthma
topic Schwerpunkt
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370781/
https://www.ncbi.nlm.nih.gov/pubmed/34421463
http://dx.doi.org/10.1007/s11298-021-2083-2
work_keys_str_mv AT meißnerthomas biologikagegenschweresinstabilesasthma